secwatch.observer — SEC 8-K summary
======================================

Issuer:     SBC Medical Group Holdings Inc (SBC)
CIK:        0001930313
Form:       8-K
Filed at:   2026-08-13T10:50:16+00:00
Accession:  0001193125-26-347825
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SBC Medical Q2 revenue up 13% to $49M; net income up 335% to $11M
-----------------------------------------------------------------

- Total revenues $49M, +13% YoY; net income attributable $11M, +335% YoY; basic EPS $0.10, +400%.
- Adjusted EBITDA $20M, +32% YoY; margin 41%, +6pts; net income margin 22%, +16pts.
- Locations up 34 YoY to 287; LTM visits 6.9M (+10%); avg spend per visit $287 (+9%).
- CEO cites AI-enabled fee increases; expects ~$15M annual service fee uplift from recent revisions.
- Cash and equivalents $184M; plans OrangeTwist US collaboration, ASEAN expansion, Longevity entry.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1930313/000119312526347825/0001193125-26-347825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1930313/000119312526347825/sbc-20260813.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-347825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer